| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |